How much does the BioXcel Therapeutics Securities Settlement pay?

Estimated payout: $1.10–$1.52. The total settlement fund is $9.8M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.

What is the claim deadline for the BioXcel Therapeutics Securities Settlement?

This settlement is closed to new claims — the deadline was June 30, 2026. Once a claim deadline passes you generally forfeit your share, even if you qualified.

Do I need proof of purchase for the BioXcel Therapeutics Securities Settlement?

Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.

Is the BioXcel Therapeutics Securities Settlement notice real, or a scam?

Strategic Claims Services is the settlement administrator for this case. Claims are filed at bioxcelsecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.

When will payments from the BioXcel Therapeutics Securities Settlement be sent?

Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for September 2, 2026; no payments can be issued before a settlement receives final approval.

Claims closedsecurities

BioXcel Therapeutics Securities Settlement

$1.10–$1.52

Last verified July 13, 2026Source: claimdepotHow ClaimWatch verifies cases

This settlement is closed to new claims — the deadline was June 30, 2026. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

BioXcel Therapeutics and its executives allegedly violated federal securities laws by making materially false or misleading statements and omissions regarding the company's business. Defendants deny wrongdoing and settled to avoid the costs and risks of continued litigation.

Do you qualify?

Anyone who purchased or acquired BioXcel Therapeutics, Inc. common stock (CUSIP: 09075P204) between March 9, 2023 and June 28, 2023, inclusive.

What you can claim

Read from the official settlement notice. Confirm the terms that apply to you on the administrator's site before filing.

Cash recovery per share
$1.52 each
Class members who submit a valid proof of claim will receive a cash payment based on the number of shares purchased and timing of purchases and sales. The estimated average recovery is approximately $1.52 per share before deduction of court-approved fees and expenses, assuming all eligible shares participate.

Who is in the class

ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED BIOXCEL THERAPEUTICS, INC. SECURITIES FROM MARCH 9, 2023 THROUGH JUNE 28, 2023, INCLUSIVE.

Quoted from the settlement notice.

How to file

Submit a valid Proof of Claim and Release Form online or by mail postmarked on or before June 30, 2026. The form requires documentation of your securities purchases. You can file online at the settlement website or mail to Strategic Claims Services, 600 N. Jackson St., Suite 205, Media, PA 19063.

Common questions

How much does the BioXcel Therapeutics Securities Settlement pay?: Estimated payout: $1.10–$1.52. The total settlement fund is $9.8M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
What is the claim deadline for the BioXcel Therapeutics Securities Settlement?: This settlement is closed to new claims — the deadline was June 30, 2026. Once a claim deadline passes you generally forfeit your share, even if you qualified.
Do I need proof of purchase for the BioXcel Therapeutics Securities Settlement?: Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
Is the BioXcel Therapeutics Securities Settlement notice real, or a scam?: Strategic Claims Services is the settlement administrator for this case. Claims are filed at bioxcelsecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
When will payments from the BioXcel Therapeutics Securities Settlement be sent?: Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for September 2, 2026; no payments can be issued before a settlement receives final approval.

In the news

Headlines via NewsAPI. ClaimWatch isn't affiliated with these publications.

New to class actions?

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

Claim deadline: June 30, 2026
Estimated payout: $1.10–$1.52
Settlement fund: $9.8M
Proof required: Yes
Class period: March 9, 2023 – June 28, 2023
Exclusion deadline: August 5, 2026
Final hearing: September 2, 2026
Case: Hills et al. v. BioXcel Therapeutics, Inc., et al.
Court: United States District Court for the District of Connecticut
Administrator: Strategic Claims Services
Administrator phone: (866) 274-4004

Official settlement website →

Case status & court docket

Federal court in ConnecticutMore from Connecticut

United States District Court for the District of Connecticut

We haven't matched this to its federal court docket yet — we keep retrying. Subscribe and we'll email you when its status or deadline changes.

More securities settlements

View all →

October 16, 2026securities

Eagle Pharma Securities Litigation Settlement

Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.

…more

December 5, 2026securities

Hut 8 Corp. Securities Class Action Settlement

Hut 8 Corp. and individual defendants are accused of alleged securities violations. The company and defendants have agreed to settle claims from investors who purchased securities during the class period without admitting wrongdoing.

December 10, 2026securities

Kornit Digital Ltd. Securities Litigation Settlement

Kornit Digital Ltd. and its executives are accused of securities fraud in this class action lawsuit. The defendants have denied all claims and admit no wrongdoing, but have agreed to settle the case for $19.5 million to eliminate the burden and expense of continued litigation.